These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21134973)

  • 21. Cross-cultural validation of the Depression Anxiety Stress Scale-21 in China.
    Wang K; Shi HS; Geng FL; Zou LQ; Tan SP; Wang Y; Neumann DL; Shum DH; Chan RC
    Psychol Assess; 2016 May; 28(5):e88-e100. PubMed ID: 26619091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.
    Ventura J; Welikson T; Ered A; Subotnik KL; Keefe RSE; Hellemann GS; Nuechterlein KH
    Early Interv Psychiatry; 2020 Feb; 14(1):106-114. PubMed ID: 31183960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.
    Mueser KT; Sayers SL; Schooler NR; Mance RM; Haas GL
    Am J Psychiatry; 1994 Oct; 151(10):1453-62. PubMed ID: 7916540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test.
    Eack SM; Greeno CG; Pogue-Geile MF; Newhill CE; Hogarty GE; Keshavan MS
    Schizophr Bull; 2010 Mar; 36(2):370-80. PubMed ID: 18648021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms.
    Bowie CR; Reichenberg A; Patterson TL; Heaton RK; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):418-25. PubMed ID: 16513862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An international perspective on assessment of negative and positive symptoms in schizophrenia.
    Moscarelli M; Maffei C; Cesana BM; Boato P; Farma T; Grilli A; Lingiardi V; Cazzullo CL
    Am J Psychiatry; 1987 Dec; 144(12):1595-8. PubMed ID: 3688286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.
    Ludwig KA; Pinkham AE; Harvey PD; Kelsven S; Penn DL
    Schizophr Res; 2017 Dec; 190():136-143. PubMed ID: 28302395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the expression of psychosis in different cultures: schizophrenia in an Indian and in a Nigerian community.
    Katz MM; Marsella A; Dube KC; Olatawura M; Takahashi R; Nakane Y; Wynne LC; Gift T; Brennan J; Sartorius N
    Cult Med Psychiatry; 1988 Sep; 12(3):331-55. PubMed ID: 3234016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional milestones and clinician ratings of everyday functioning in people with schizophrenia: overlap between milestones and specificity of ratings.
    Harvey PD; Sabbag S; Prestia D; Durand D; Twamley EW; Patterson TL
    J Psychiatr Res; 2012 Dec; 46(12):1546-52. PubMed ID: 22979993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel.
    Leifker FR; Patterson TL; Heaton RK; Harvey PD
    Schizophr Bull; 2011 Mar; 37(2):334-43. PubMed ID: 19525354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial validation of a computerized version of the UCSD Performance-Based Skills Assessment (C-UPSA) for assessing functioning in schizophrenia.
    Moore RC; Harmell AL; Ho J; Patterson TL; Eyler LT; Jeste DV; Mausbach BT
    Schizophr Res; 2013 Mar; 144(1-3):87-92. PubMed ID: 23375625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scales for evaluating depressive symptoms in Chinese patients with schizophrenia.
    Liu H; Zhang H; Xiao W; Liu Q; Fu P; Chen J; Wang G; Yang F; Wang G; Wang X; Li L
    J Nerv Ment Dis; 2009 Feb; 197(2):140-2. PubMed ID: 19214051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional capacity: a new framework for the assessment of everyday functioning in schizophrenia.
    Mantovani LM; Teixeira AL; Salgado JV
    Braz J Psychiatry; 2015; 37(3):249-55. PubMed ID: 26376057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.
    Xie DJ; Shi HS; Lui SSY; Shi C; Li Y; Ho KKY; Hung KSY; Li WX; Yi ZH; Cheung EFC; Kring AM; Chan RCK
    Schizophr Bull; 2018 Oct; 44(suppl_2):S547-S555. PubMed ID: 29471331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A polydiagnostic approach to the differences in the symptoms of schizophrenia in different cultural and ethnic populations.
    Maslowski J; Jansen van Rensburg D; Mthoko N
    Acta Psychiatr Scand; 1998 Jul; 98(1):41-6. PubMed ID: 9696513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Hurford IM; Ventura J; Marder SR; Reise SP; Bilder RM
    Schizophr Res; 2018 May; 195():327-333. PubMed ID: 28918221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-cultural psychometric assessment of the VAGUS insight into psychosis scale - Spanish version.
    de León PP; Gerretsen P; Shah P; Saracco-Alvarez R; Graff-Guerrero A; Fresán A
    Psychiatry Res; 2018 Jan; 259():450-454. PubMed ID: 29179136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a four items version of the Functional Remission of General Schizophrenia scale (the mini-FROGS) to capture the functional benefits of clinical remission.
    Mallet J; Lancrenon S; Llorca PM; Lançon C; Baylé FJ; Gorwood P
    Eur Psychiatry; 2018 Jan; 47():35-41. PubMed ID: 29100170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.